Stop Tip-toeing Around Toe-walking
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose of this study is to explore the interplay among nervous-, musculoskeletal-, and psychological systems and how they impact toe-walking behavior, and vice versa. Sub-Project 1 is to analyze the feasibility of the developed virtual reality (VR) environment, in 10 TD and sCP children respectively. It is assess the effects of VR immersion on predefined static and dynamic stability parameters. Sub-Project 2: After adjustments have been made following Sub-Project 1 regarding the study procedure, technical factors or the parameters of interest etc., the optimized study procedure is implemented in Sub-Project 2 (20 to 25 TD will be included). Sub-Project 3: After adjustments have been made following Sub-Project 1 regarding the study procedure, technical factors or the parameters of interest etc., the optimized study procedure is implemented in Sub-Project3 (20 to 25 sCP will be included)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 10, 2021
CompletedStudy Start
First participant enrolled
August 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedOctober 18, 2023
October 1, 2023
2.1 years
May 3, 2021
October 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Static stability assessed by Center of Pressure (COP) shifts in anterior-posterior and mediolateral directions under each limb
COP shifts in anterior-posterior and mediolateral directions under each limb are assessed via the use of two force plates embedded in the floor (Kistler Instrumente AG, Winterthur, Switzerland, sample rate 1500 Hz) (mean value of three repetitions)
one time assessment at baseline (complete baseline assessments up to 3 hours)
Static stability assessed by Visual Analogue Scale (VAS)
Self-perceived degree of safety during walking in the VR environment will be assessed using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")
one time assessment at baseline (complete baseline assessments up to 3 hours)
Static stability assessed by Ratio between H-reflex and M-wave amplitude
Ratio between H-reflex and M-wave amplitude, measured through soleus muscle in affected side of hemiplegic sCP and in none-dominant side for diplegic CP and TD (recruitment curve of the H-reflex and the M-wave of the Soleus elicited by stimulating the tibial nerve while standing)
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability assessed by COP shifts in combination with base of support trajectory
COP shifts in combination with base of support trajectory assessed via the use of four force plates embedded in the floor (mean value of three repetitions)
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability assessed by number of muscle synergies
Number of muscle synergies assessed via the use of a sixteen-channel surface electromyography system
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability assessed by interlimb coordination
Interlimb coordination will be calculated by using kinematic data from lower and upper extremities
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS)
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")
one time assessment at baseline (complete baseline assessments up to 3 hours)
Secondary Outcomes (6)
Dynamic stability measurement assessed by kinematic data of upper & lower extremities (joint angles in degree)
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability measurement assessed by spatiotemporal parameters: walking speed (normalized to leg length) [m/(s*mm)]
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability measurement assessed by spatiotemporal parameters: stride width [s]
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability measurement assessed by spatiotemporal parameters: double support time [s]
one time assessment at baseline (complete baseline assessments up to 3 hours)
Dynamic stability measurement assessed by spatiotemporal parameters: cadence [steps/min]
one time assessment at baseline (complete baseline assessments up to 3 hours)
- +1 more secondary outcomes
Study Arms (2)
Typically Developing (TD) children
EXPERIMENTALStatic stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) who are typically developing, 3) able to stand and walk alone without using assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.
Spastic Cerebral Palsy (sCP) children
EXPERIMENTALStatic stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS) \[98\], 3) being able to stand and walk alone without assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.
Interventions
The child stands barefoot on dual force platforms in two (CP: three) different conditions: barefoot and with shoes (CP: and with orthosis). Each condition is recorded three times each lasting for 30s, and 30s rest between them. Both conditions are recorded with and without wearing a headset. The order of conditions (within each Virtual Reality ("VR)-condition") is randomized. For each condition, the child rests in a comfortable position for 20s with the heels on the same level and arms hanging at their sides. Between both "VR-conditions", the child rests for 120 s.
The child walks at their normal walking speed on a 10-m walkway in two (CP: three) different conditions: barefoot and with shoes (CP: and with orthosis). For each condition, at least six error-free trials are recorded. Errors in data may occur due to hidden or lost markers during walking or software interruptions. Both conditions are recorded with and without wearing a headset. The order of conditions (within each "VR-condition") is randomized.
Eligibility Criteria
You may qualify if:
- between the age of 7 and 18 years
- who are typically developing
- able to stand and walk alone without using assistance or assistive devices
- able to place their feet flat on the force platforms
- with enough German language skills to follow the instructions
- between the age of 7 and 18 years
- with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS)
- being able to stand and walk alone without assistance or assistive devices
- able to place their feet flat on the force platforms
- with enough German language skills to follow the instructions
You may not qualify if:
- severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
- any vestibular problems (e.g. severe motion sickness)
- history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
- prior experience of VR to ensure a comparable baseline between subjects
- severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
- severe knee flexion gait (\>45°)
- walking capacity \<50m
- botulinum toxin type A treatment (past 6 months)
- orthopedic surgery of upper or lower extremities (past 12 months)
- any vestibular problems (e.g. severe motion sickness or dizziness)
- history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
- prior experience of VR as they may already be adapted to VR.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research
Basel, 4056, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heide Elke Viehweger, Prof. Dr. med.
University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 10, 2021
Study Start
August 11, 2021
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
October 18, 2023
Record last verified: 2023-10